Manuscripts
Showing 1595 manuscripts.
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study
Citation
Heather Ribaudo, Ph.D., David W. Haas, M.D., Camlin Tierney, Ph.D., Richard B. Kim, M.D., Grant R Wilkinson, Ph.D., D.Sc., Roy (Trip) Gulick, M.D., M.P.H., David B. Clifford, M.D., Catia Marzolini, Courtney V. Fletcher, Pharm.D., Karen T. Tashima, M.D., Daniel R. Kuritzkes, M.D., Edward P. Acosta, Pharm.D. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study. Clinical Infectious Diseases. 2006 Feb 01; 42(3):401-7.Year
2006
Journal
Clinical Infectious Diseases
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission
Citation
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006 Jun 12; 20(9):1313-21. PMID: 16816561.Year
2006
Journal
AIDS
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi
Citation
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi. Sexually Transmitted Diseases. 2006 Oct 01; 33(10):604-9. PMID: 16601659; PMCID: PMC2743105.Year
2006
Journal
Sexually Transmitted Diseases
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission
Citation
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006 Jan 09; 20(2):217-22. PMID: 16511414.Year
2006
Journal
AIDS
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.
Citation
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. American Journal of Obstetrics and Gynecology. 2006 Oct 01; 195(4):1065-74. PMID: 16875654.Year
2006
Journal
American Journal of Obstetrics and Gynecology
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Citation
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. American Journal of Obstetrics and Gynecology. 2006 Aug 15; 42(5):610-3. PMID: 16773030.Year
2006
Journal
American Journal of Obstetrics and Gynecology
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
Citation
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes. 2006 Aug 01; 42(4):518-521. PMID: 16810119.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Sensitivity of the ViroSeqTM HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D
Citation
Sensitivity of the ViroSeqTM HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. 2006 Sep 01; 8(4):430-2. PMID: 16931582; PMCID: PMC1867617.Year
2006
Indinavir impairs endothelial function in healthy HIV-negative men
Citation
Sudha S. Shankar, M.D., Michael P. Dube, M.D., J. Christopher Gorski, Ph.D., James E. Klaunig, Ph.D., M.D., Helmut O. Steinberg, M.D. Indinavir impairs endothelial function in healthy HIV-negative men. American Heart Journal. 2005 Nov 01; 150(5):933.Year
2005
Journal
American Heart Journal
S phase lymphocytes in HIV disease have a central memory phenotype and rarely have evidence for recent T cell receptor engagement
Citation
Scott F. Sieg, Ph.D., Benigno Rodriguez, M.D., Robert Asaad, M.D., Wei Jiang, M.D., M.S., Douglas A. Bazdar, Michael M. Lederman, M.D. S phase lymphocytes in HIV disease have a central memory phenotype and rarely have evidence for recent T cell receptor engagement. Journal of Infectious Diseases. 2005 Jul 01; 192:67-70.Year
2005
Journal
Journal of Infectious Diseases